Skip to navigation menu Skip to content
Informational Alert

Due to a measles case in the community, please call before coming to Seattle Children’s if you or your child has potential measles symptoms.

High Priority Alert

Masking and Visitation Changes: Due to high rates of respiratory illnesses in our community, we’ve made changes to our masking and visitation guidelines .

Illustration of a calendarIllustration of a document pageIllustration of a heart over a handIllustration of an envelopeIllustration of the letter i inside a circleIllustration of a map markerIllustration of a caduceusIllustration of a user with a plus signIllustration of a telephoneIllustration of a question mark inside a circleIllustration of a video cameraDocument with a PDF label

Kalume Laboratory

Pursuing New Treatments for Epilepsy

The Kalume Laboratory investigates the mechanisms that drive epilepsy and related conditions, with the goal of making discoveries that lead to improved treatments for affected children and adults.

Much of the laboratory's current research focuses on Dravet syndrome, a severe, life-threatening form of epilepsy that starts in infancy. Dravet syndrome is caused by mutations in SCN1A, a gene that produces the sodium channel NaV 1.1. The laboratory has made important progress toward understanding how mutations in this gene cause Dravet syndrome, which in turn can lead to sudden unexpected death.

Kalume and his team are also studying why epilepsy leads to sleep disorders, and investigating the mechanisms that allow the ketogenic diet – a high-fat dietary regimen – to suppress seizures.